journal article·2022-01

Influence of enantiomeric polylysine grafted on gold nanorods on the uptake and inflammatory response of bone marrow‐derived macrophages in vitro

Wajiha Ahmed, Haolan Zhang, Changyou Gao

Publisher page

Abstract

Abstract The macrophages take significant roles in homeostasis, phagocytosis of pathogenic organisms, and modulation of host defense and inflammatory processes. In this study, the enantiomeric poly‐D‐lysine (PDL) and poly‐L‐lysine (PLL) were conjugated to gold nanorods (AuNRs) to study their influence on the polarization of macrophages. The AuNRs capped with cetyl trimethyl ammonium bromide (CTAB) (AuNRs@CTAB) exhibited larger toxicity to macrophages when their concentration was higher than 50 μg/ml, whereas the AuNRs@PDL and AuNRs@PLL showed neglectable toxicity at the same concentration compared with the control. The AuNRs@PDL and AuNRs@PLL were internalized into the macrophages with a higher value than the AuNRs@CTAB as revealed by transmission electron microscopy (TEM) and inductively coupled plasma mass spectrometry (ICP‐MS) characterization. Unlike the grafted PDL/PLL on flat substrates, the AuNRs@PDL and AuNRs@PLL were not able to polarize M0 macrophages to any other phenotype after internalization as confirmed by ELISA, flow cytometry, and fluorescence microscopy analysis. Nonetheless, the expression of M1 phenotype markers was reduced after the internalization of AuNRs@PDL and AuNRs@PLL by M1 macrophages. The assays of ELISA, flow cytometry, and reactive oxygen species levels exhibited decrease in inflammation of the M1 macrophages.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immune cells in cancer · Immunotherapy and Immune Responses · Antimicrobial Peptides and Activities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering Zhejiang University Hangzhou China

References (69)

Show source-provided references
1. 10.1146/annurev.pharmtox.010909.10581210.1146/annurev.pharmtox.010909.105812 ↗
2. 10.1038/nature1203410.1038/nature12034 ↗
3. 10.1002/path.413310.1002/path.4133 ↗
4. 10.1172/JCI5964310.1172/JCI59643 ↗
5. 10.1002/eji.20114167010.1002/eji.201141670 ↗
6. 10.1002/eji.20093988910.1002/eji.200939889 ↗
7. 10.1146/annurev.immunol.021908.13253210.1146/annurev.immunol.021908.132532 ↗
8. 10.1016/j.immuni.2010.05.00710.1016/j.immuni.2010.05.007 ↗
9. 10.1007/978-0-387-77516-6_1310.1007/978-0-387-77516-6_13 ↗
10. 10.1186/s12951-018-0383-910.1186/s12951-018-0383-9 ↗
11. 10.1039/C1CS15209B10.1039/C1CS15209B ↗
12. 10.1021/la204143g10.1021/la204143g ↗
13. 10.1021/acsami.5b0840510.1021/acsami.5b08405 ↗
14. 10.1039/c1cc10855g10.1039/c1cc10855g ↗
15. 10.1016/j.apsusc.2010.07.02910.1016/j.apsusc.2010.07.029 ↗
16. 10.1016/j.jconrel.2010.08.02710.1016/j.jconrel.2010.08.027 ↗
17. 10.1016/j.biomaterials.2020.12001210.1016/j.biomaterials.2020.120012 ↗
18. Shi Y · 2018 · 31
19. 10.1016/B978-0-12-801238-3.05215-610.1016/B978-0-12-801238-3.05215-6 ↗
20. 10.1016/j.trecan.2018.02.00810.1016/j.trecan.2018.02.008 ↗
21. 10.1002/smll.20110000110.1002/smll.201100001 ↗
22. Endocytosis of particle formulations by macrophages and its application to clinical treatment
23. 10.1021/acsami.8b0471810.1021/acsami.8b04718 ↗
24. Macrophage repolarization using CD44‐targeting hyaluronic acid–polylactide nanoparticles containing curcumin
25. 10.1016/j.biomaterials.2019.03.03410.1016/j.biomaterials.2019.03.034 ↗
26. 10.1186/s40425-019-0817-410.1186/s40425-019-0817-4 ↗
27. 10.1186/s12951-020-00593-710.1186/s12951-020-00593-7 ↗
28. 10.1021/acsnano.8b0878510.1021/acsnano.8b08785 ↗
29. 10.1016/j.apsb.2017.09.00510.1016/j.apsb.2017.09.005 ↗
30. 10.1039/D0CS00908C10.1039/D0CS00908C ↗
31. 10.3390/bioengineering602005310.3390/bioengineering6020053 ↗
32. 10.1016/j.addr.2009.11.00710.1016/j.addr.2009.11.007 ↗
33. 10.1007/s11051-007-9212-z10.1007/s11051-007-9212-z ↗
34. 10.1021/ar200260p10.1021/ar200260p ↗
35. 10.3762/bjnano.8.3910.3762/bjnano.8.39 ↗
36. 10.1038/s41598-018-26393-610.1038/s41598-018-26393-6 ↗
37. 10.1021/acs.jafc.8b0029210.1021/acs.jafc.8b00292 ↗
38. 10.1186/s12866-018-1227-310.1186/s12866-018-1227-3 ↗
39. 10.1021/acs.nanolett.8b0515010.1021/acs.nanolett.8b05150 ↗
40. 10.1021/acsami.9b1591010.1021/acsami.9b15910 ↗
41. 10.1021/nn100262h10.1021/nn100262h ↗
42. Differential uptake of gold‐nanorods promotes identification of M1/M2 subtype of macrophage by flow cytometry
43. 10.1021/cm020732l10.1021/cm020732l ↗
44. 10.1016/j.bioactmat.2018.05.00310.1016/j.bioactmat.2018.05.003 ↗
45. 10.1186/s12951-018-0377-710.1186/s12951-018-0377-7 ↗
46. 10.1021/la049463z10.1021/la049463z ↗
47. 10.3390/polym1106093910.3390/polym11060939 ↗
48. 10.1088/0957-4484/27/25/25510110.1088/0957-4484/27/25/255101 ↗
49. 10.1021/ar800035u10.1021/ar800035u ↗
50. AlkilanyAM NagariaPK HexelCR ShawTJ MurphyCJ WyattMD.Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects small.2009;5(6):701‐708.10.1002/smll.200801546 ↗
51. 10.1021/bm301048410.1021/bm3010484 ↗
52. 10.1088/0957-4484/21/35/35510210.1088/0957-4484/21/35/355102 ↗
53. 10.1021/la803361y10.1021/la803361y ↗
54. The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions?
55. 10.1007/s00204-010-0546-410.1007/s00204-010-0546-4 ↗
56. 10.1002/smll.20100046310.1002/smll.201000463 ↗
57. 10.7150/thno.1418410.7150/thno.14184 ↗
58. 10.1002/adhm.20140075110.1002/adhm.201400751 ↗
59. 10.1016/j.biomaterials.2010.06.05110.1016/j.biomaterials.2010.06.051 ↗
60. 10.1016/j.ejpb.2010.11.01010.1016/j.ejpb.2010.11.010 ↗
61. 10.1038/srep3159510.1038/srep31595 ↗
62. 10.1039/C9RA10563H10.1039/C9RA10563H ↗
63. 10.1002/ppsc.20120011510.1002/ppsc.201200115 ↗
64. 10.1016/j.freeradbiomed.2011.09.03010.1016/j.freeradbiomed.2011.09.030 ↗
65. 10.1038/ni.186310.1038/ni.1863 ↗
66. 10.1146/annurev.pharmtox.010909.10581910.1146/annurev.pharmtox.010909.105819 ↗
67. 10.1021/nn404055310.1021/nn4040553 ↗
68. 10.1039/C7TB03080K10.1039/C7TB03080K ↗
69. 10.1016/j.cyto.2008.01.00610.1016/j.cyto.2008.01.006 ↗